Catheterization and Cardiovascular Interventions

Pediatric and Congenital Heart Disease

New approach to septal ablation: Glue (cyanoacrylate) septal ablation

Corresponding Author

Ali Oto MD, Prof, FESC, FACC, FHRS

Hacettepe University, Faculty of Medicine, Department of Cardiology, Altindag, Ankara, Turkey

Hacettepe University, Faculty of Medicine, Department of Cardiology, Altindag, Ankara, TurkeySearch for more papers by this author

Kudret Aytemir MD, Prof, FESC,

Kudret Aytemir MD, Prof, FESC

Hacettepe University, Faculty of Medicine, Department of Cardiology, Altindag, Ankara, Turkey

Search for more papers by this author

Ali Deniz MD,

Ali Deniz MD

[email protected]

Hacettepe University, Faculty of Medicine, Department of Cardiology, Altindag, Ankara, Turkey

Search for more papers by this author

Ali Oto MD, Prof, FESC, FACC, FHRS,

Corresponding Author

Ali Oto MD, Prof, FESC, FACC, FHRS

Hacettepe University, Faculty of Medicine, Department of Cardiology, Altindag, Ankara, Turkey

Hacettepe University, Faculty of Medicine, Department of Cardiology, Altindag, Ankara, TurkeySearch for more papers by this author

Kudret Aytemir MD, Prof, FESC,

Kudret Aytemir MD, Prof, FESC

Hacettepe University, Faculty of Medicine, Department of Cardiology, Altindag, Ankara, Turkey

Search for more papers by this author

Ali Deniz MD,

Ali Deniz MD

[email protected]

Hacettepe University, Faculty of Medicine, Department of Cardiology, Altindag, Ankara, Turkey

Search for more papers by this author

First published: 24 May 2007

https://doi.org/10.1002/ccd.21003

Citations: 12

Share a link

Email
Wechat
Bluesky

Abstract

Alcohol septal ablation is an alternative way of treatment in hypertrophic obstructive cardiomyopathy patients who are refractory to medical treatment. This case report describes a new way of septal ablation with glue (cyanoacrylate) in a HOCM patient who has extensive collateral to posterior descending coronary artery which precludes alcohol ablation. © 2007 Wiley-Liss, Inc.

REFERENCES

1 Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995; 346: 211–214.
10.1016/S0140-6736(95)91267-3
CAS PubMed Web of Science® Google Scholar
2 Holmes DR, Valeti US, Nishimura RA. Alcohol septal ablation for hypertrophic cardiomyopathy: Indications and technique. Catheter Cardiovasc Interv 2005; 66: 375–389.
10.1002/ccd.20500
PubMed Web of Science® Google Scholar
3 Pollak JS, White RI. The use of cyanoacrylate adhesives in peripheral embolization. J Vasc Interv Radiol 2001; 12: 907–913.
10.1016/S1051-0443(07)61568-1
CAS PubMed Web of Science® Google Scholar
4 Knight C, Kurbaan AS, Seggewiss H, et al. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: Outcome in the first series of patients. Circulation 1997; 95: 2075–2081.
10.1161/01.CIR.95.8.2075
CAS PubMed Web of Science® Google Scholar
5 Perez MA, Valenzuela GM, Blanes JG, et al. Balloon rupture and alcohol leakage into the left anterior descending coronary artery during percutaneous septal ablation for hypertrophic obstructive cardiomyopathy. Rev Esp Cardiol 2005; 58: 872–874.
10.1016/S1885-5857(06)60517-3
PubMed Web of Science® Google Scholar
6 Aroney CN, Goh TH, Hourigan LA, et al. Ventricular septal rupture following nonsurgical septal reduction for hypertrophic cardiomyopathy: Treatment with percutaneous closure. Catheter Cardivasc Interv 2004; 61: 411–414.
10.1002/ccd.10767
PubMed Web of Science® Google Scholar
7 Agarwal SC, Purcell IF, Furniss SS. Apical myocardial injury caused by collateralization of a septal artery during ethanol septal ablation. Heart 2005; 91: e2.
10.1136/hrt.2004.047993
CAS PubMed Web of Science® Google Scholar
8 Raute-Kreinsen U. Morphology of necrosis and repair after transcoronary ethanol ablation of septal hypertrophy. Pathol Res Pract 2003; 199: 121–127.
10.1078/0344-0338-00364
PubMed Web of Science® Google Scholar
9 RS Cotran, V Kumar, T Collins, editors. Robbins Pathologic Basis of Disease, 6th ed. Philadelphia, PA: Sounders; 1999. p 558.
Google Scholar
10 Oomman A, Ramachandran P, Subramanyan K, et al. Transluminal septal myocardial ablation in drug-resistant hypertrophic obstructive cardiomyopathy: 18-month follow-up results. J Invasive Cardiol 2001; 13: 526–530.
CAS PubMed Google Scholar
11 Gaspar J, Martinez-Rios M, Vonderwalde C, et al. Pericardium-covered stent for septal myocardial ablation in hypertrophic obstructive cardiomyopathy. Catheter Cardiovasc Interv 1999; 47: 73–79.
10.1002/(SICI)1522-726X(199905)47:1<73::AID-CCD17>3.0.CO;2-Z
CAS PubMed Web of Science® Google Scholar
12 Uhlrich F, Waigand J, Gross CM, et al. Transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy: Embolization with particles instead of alcohol. Am J Cardiol 1999; 84 ( Suppl 6A): 123P.
Google Scholar
13 Iacob M, Pinte F, Tintoiu I, et al. Microcoil embolisation for ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy. Pol Heart J 2004; 61: 10.
Google Scholar
14 Seggewiss H, Gleichmann U, Faber L, et al. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute result and 3-month follow-up in 25 patients. J Am Coll Cardiol 1998; 31: 252–258.
10.1016/S0735-1097(97)00508-1
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume69, Issue7

1 June 2007

Pages 1021-1025

SCAI Member Sign in

New approach to septal ablation: Glue (cyanoacrylate) septal ablation

Abstract

REFERENCES

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

New approach to septal ablation: Glue (cyanoacrylate) septal ablation

Abstract

REFERENCES

Citing Literature

References

Related

Information